Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorShirley Ryan AbilityLab

About this trial

This study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population. The breathing intervention, known as Acute Intermittent Hypoxia (AIH), involves breathing brief bouts of low levels of oxygen. Research has found AIH to be a safe and effective intervention resulting in increased ankle strength in people with MS. Here, the study examines arm and hand function before and after AIH. In order to better understand the brain and spinal cord response to AIH, the investigators will measure muscle response, and signals sent from the brain to the arm muscles before and after AIH.

Eligibility criteria

Qualifiers

Diagnosis of relapsing-remitting MS according to the McDonald criteria, over 5 years ago

Relapse free for at least 6 months

Expanded Disability Status Scale (EDSS) ≤7

Index finger abduction strength <5 according to Medical Research Council Scale, or 9-Hole Peg Test score >20 seconds in at least one hand

Disqualifiers

Another diagnosis (e.g., peripheral neuropathies or orthopedic) affecting upper limb function

Mini-Mental State Examination (MMSE) score <24

Modified Ashworth Scale score >3 on elbow joint

Uncontrolled hypertension or hypotension (outside 140/90 and 85/55 mmHg)

Trial design

Treatments tested in this trial

  • Acute Intermittent Hypoxia
  • Sham Acute Intermittent Hypoxia

Treatment groups

22 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Shirley Ryan AbilityLab

Lead sponsor

National Multiple Sclerosis Society

Collaborator